Literature DB >> 17534458

The 2007 Canadian Hypertension Education Program recommendations: the scientific summary - an annual update.

.   

Abstract

The present paper summarizes and highlights key messages of the 2007 Canadian Hypertension Education Program recommendations for the management and diagnosis of hypertension. This is the eighth annual update. Important new messages in the 2007 Canadian Hypertension Education Program recommendations emphasize the need for assessing adults with high normal blood pressure on an annual basis and reducing sodium in the diet of Canadians to less than 100 mmol/day. These new recommendations still need to be incorporated into the older but still important considerations for the diagnosis, management and treatment of patients with hypertension, namely, assessing blood pressure in all adults at all appropriate visits, expediting the diagnosis of hypertension, assessing and managing global cardiovascular risk, emphasizing that lifestyle modifications are the cornerstone of antihypertensive therapy, treating to target to achieve optimum cardiovascular risk reduction, using combinations of antihypertensive medications and lifestyle to achieve recommended targets and focusing on adherence to therapy. Minor changes in pharmacological therapies and some new recommendations on routine laboratory tests are discussed.

Entities:  

Mesh:

Year:  2007        PMID: 17534458      PMCID: PMC2650755          DOI: 10.1016/s0828-282x(07)70796-1

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  45 in total

1.  Impact of dietary and lifestyle factors on the prevalence of hypertension in Western populations.

Authors:  J M Geleijnse; D E Grobbee; F J Kok
Journal:  J Hum Hypertens       Date:  2005-12       Impact factor: 3.012

2.  Effects of dietary saturated, monounsaturated, and n-3 fatty acids on blood pressure in healthy subjects.

Authors:  Birthe M Rasmussen; Bengt Vessby; Matti Uusitupa; Lars Berglund; Eva Pedersen; Gabrielle Riccardi; Angela A Rivellese; Linda Tapsell; Kjeld Hermansen
Journal:  Am J Clin Nutr       Date:  2006-02       Impact factor: 7.045

3.  The impact of the Canadian Hypertension Education Program on antihypertensive prescribing trends.

Authors:  Norman R C Campbell; Karen Tu; Rollin Brant; Minh Duong-Hua; Finlay A McAlister
Journal:  Hypertension       Date:  2005-12-12       Impact factor: 10.190

4.  Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial.

Authors:  Lawrence J Appel; Frank M Sacks; Vincent J Carey; Eva Obarzanek; Janis F Swain; Edgar R Miller; Paul R Conlin; Thomas P Erlinger; Bernard A Rosner; Nancy M Laranjo; Jeanne Charleston; Phyllis McCarron; Louise M Bishop
Journal:  JAMA       Date:  2005-11-16       Impact factor: 56.272

5.  Hypertension labelling was associated with poorer self-rated health in the Third US National Health and Nutrition Examination Survey.

Authors:  S D Barger; M F Muldoon
Journal:  J Hum Hypertens       Date:  2006-02       Impact factor: 3.012

6.  The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients.

Authors:  Lisheng Liu; Yuqing Zhang; Guozhang Liu; Wei Li; Xuezhong Zhang; Alberto Zanchetti
Journal:  J Hypertens       Date:  2005-12       Impact factor: 4.844

7.  Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial.

Authors:  Patricia J Elmer; Eva Obarzanek; William M Vollmer; Denise Simons-Morton; Victor J Stevens; Deborah Rohm Young; Pao-Hwa Lin; Catherine Champagne; David W Harsha; Laura P Svetkey; Jamy Ard; Phillip J Brantley; Michael A Proschan; Thomas P Erlinger; Lawrence J Appel
Journal:  Ann Intern Med       Date:  2006-04-04       Impact factor: 25.391

8.  Feasibility of treating prehypertension with an angiotensin-receptor blocker.

Authors:  Stevo Julius; Shawna D Nesbitt; Brent M Egan; Michael A Weber; Eric L Michelson; Niko Kaciroti; Henry R Black; Richard H Grimm; Franz H Messerli; Suzanne Oparil; M Anthony Schork
Journal:  N Engl J Med       Date:  2006-03-14       Impact factor: 91.245

9.  Reductions in albuminuria and in electrocardiographic left ventricular hypertrophy independently improve prognosis in hypertension: the LIFE study.

Authors:  Michael H Olsen; Kristian Wachtell; Hans Ibsen; Lars H Lindholm; Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Lasse Oikarinen; Peter M Okin
Journal:  J Hypertens       Date:  2006-04       Impact factor: 4.844

10.  Sodium intake and mortality in the NHANES II follow-up study.

Authors:  Hillel W Cohen; Susan M Hailpern; Jing Fang; Michael H Alderman
Journal:  Am J Med       Date:  2006-03       Impact factor: 4.965

View more
  7 in total

1.  Rheumatologist and Primary Care Management of Cardiovascular Disease Risk in Rheumatoid Arthritis: Patient and Provider Perspectives.

Authors:  Christie M Bartels; Tonya J Roberts; Karen E Hansen; Elizabeth A Jacobs; Andrea Gilmore; Courtney Maxcy; Barbara J Bowers
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-04       Impact factor: 4.794

2.  Musings regarding hypertension.

Authors:  Eldon R Smith
Journal:  Can J Cardiol       Date:  2007-05-15       Impact factor: 5.223

3.  Dihydropyridine calcium channel blockers and cardiovascular outcomes in elderly patients: a population-based study.

Authors:  Claudia Bucci; Muhammad M Mamdani; David N Juurlink; Jack V Tu
Journal:  Can J Cardiol       Date:  2008-08       Impact factor: 5.223

Review 4.  Clinical significance of home blood pressure and its possible practical application.

Authors:  Yutaka Imai
Journal:  Clin Exp Nephrol       Date:  2013-07-03       Impact factor: 2.801

5.  Recording blood pressure readings in elderly patients' charts: what patient and physician characteristics make it more likely?

Authors:  Joel Broomfield; Nicola Schieda; Shannon M Sullivan; Larry W Chambers; Janusz Kaczorowski; Tina Karwalajtys
Journal:  Can Fam Physician       Date:  2008-02       Impact factor: 3.275

Review 6.  Yoga and hypertension.

Authors:  Debbie Cohen; Raymond R Townsend
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-10       Impact factor: 3.738

7.  Antihypertensive effects of new dihydropyridine derivatives on phenylephrine-raised blood pressure in rats.

Authors:  Sara Rowghani Haghighi Fard; Ramin Miri; Ali Akbar Nekooeian
Journal:  Res Pharm Sci       Date:  2016-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.